§ 31-52-4. Eligibility Criteria

In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person:

1. Has a terminal illness;
2. Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration;
3. Has been given a recommendation by the physician for an investigational drug, biological product, or device; and
4. Has given written informed consent for the use of the investigational drug, biological product, or device.

History. Code 1981, § 31-52-4 , enacted by Ga. L. 2016, p. 345, § 1/HB 34.